A national audit of the use of neuromuscular blocking drugs in cardiac anaesthesia
Briggs, S., Goodyear, P., Thomas, R., Strike, P. and Smith, D. (2006) A national audit of the use of neuromuscular blocking drugs in cardiac anaesthesia. Anaesthesia, 61, (1), p.95. (doi:10.1111/j.1365-2044.2005.04439.x).
Full text not available from this repository.
Residual neuromuscular blockade contributes to postoperative
morbidity and mortality and is more prevalent with long acting nondepolarising neuromuscular blocking drugs such as pancuronium . Reducing time between surgery and extubation may lead to residual neuromuscular blockade in cardiac patients, particularly with long acting drugs . We performed an audit of use of neuromuscular blocking drugs in the United Kingdom between 2002 and 2004.
|Additional Information:||Abstracts presented at the spring meeting of the Association of Cardiothoracic Anaesthetists (ACTA) in Cambridge, July 2005|
|Subjects:||R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
R Medicine > RS Pharmacy and materia medica
|Divisions:||University Structure - Pre August 2011 > School of Medicine > Cancer Sciences
|Date Deposited:||02 Sep 2008|
|Last Modified:||06 Aug 2015 02:51|
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)